These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35845348)

  • 1. New-onset pemphigus vegetans and pemphigus foliaceus after SARS-CoV-2 vaccination: A report of 2 cases.
    Gui H; Young PA; So JY; Pol-Rodriguez M; Rieger KE; Lewis MA; Winge MCG; Bae GH
    JAAD Case Rep; 2022 Sep; 27():94-98. PubMed ID: 35845348
    [No Abstract]   [Full Text] [Related]  

  • 2. Pemphigus vegetans with paronychia-like changes resistant to rituximab therapy.
    Ayoubi N; Rudnick E; Motaparthi K
    Dermatol Ther; 2020 Jul; 33(4):e13515. PubMed ID: 32367637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum eosinophil cationic protein and transforming growth factor-α levels in a patient with pemphigus vegetans.
    Matsuyama K; Tokuzumi M; Takahashi T; Shu E; Takagi H; Hashimoto T; Seishima M
    Clin Exp Dermatol; 2018 Dec; 43(8):917-920. PubMed ID: 29862541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
    Akoglu G
    Dermatol Ther; 2022 May; 35(5):e15396. PubMed ID: 35187768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localized pemphigus vegetans of the nose and lips: A classic case of a rare entity.
    Magro C; Grossman ME; Karaaslan S; Skrokov R; Valinotti M
    JAAD Case Rep; 2022 Jul; 25():67-71. PubMed ID: 35769193
    [No Abstract]   [Full Text] [Related]  

  • 6. New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.
    Mohaghegh F; Hatami P; Refaghat A; Mehdizadeh M; Aryanian Z; Mohandesi NA; Afshar ZM
    Clin Case Rep; 2022 Jun; 10(6):e05910. PubMed ID: 35662780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aureomycin therapy of pemphigus foliaceus, pemphigus vegetans and severe pemphigus vulgaris].
    ALAYON F; MARTINS de CASTRO AF; FONZARI M
    An Bras Derm Sifilogr; 1950 Jun; 25(2):111-4. PubMed ID: 14847189
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of anti-desmocollins I and II autoantibodies in two cases of Hallopeau type pemphigus vegetans by immunoblot analysis.
    Hashimoto K; Hashimoto T; Higashiyama M; Nishikawa T; Garrod DR; Yoshikawa K
    J Dermatol Sci; 1994 Apr; 7(2):100-6. PubMed ID: 8060912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A clinico-pathological study of 70 cases of pemphigus.
    Arya SR; Valand AG; Krishna K
    Indian J Dermatol Venereol Leprol; 1999; 65(4):168-71. PubMed ID: 20921646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pemphigus vulgaris and foliaceus localized to the nose: Report of 2 cases.
    Safadi MG; Turowski M; Murray T; Zahner S; Aronson I
    JAAD Case Rep; 2021 Sep; 15():129-132. PubMed ID: 34471665
    [No Abstract]   [Full Text] [Related]  

  • 11. Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.
    Ohata C; Ishii N; Furumura M
    J Cutan Pathol; 2014 Nov; 41(11):880-9. PubMed ID: 25265985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of BIOCHIP technique in diagnosis of different types of pemphigus: Vulgaris and foliaceus.
    Adaszewska A; Kalinska-Bienias A; Jagielski P; Wozniak K; Kowalewski C
    J Immunol Methods; 2019 May; 468():35-39. PubMed ID: 30910537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of pemphigus foliaceus, pemphigus vegetans and severe pemphigus vulgaris with aureomycin].
    ALAYON FO; de CASTRO AF; FONZARI M
    An Paul Med Cir; 1950 May; 59(5):461-4. PubMed ID: 15432900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of pemphigus foliaceus, pemphigus vegetans and severe pemphigus vulgaris with aureomycin].
    ALAYON FO; DE CASTRO FM; FONZARI M
    Rev Paul Med; 1950 Jan; 36(1):51-3. PubMed ID: 15405239
    [No Abstract]   [Full Text] [Related]  

  • 15. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphigus foliaceus.
    Loiseau P; Lecleach L; Prost C; Lepage V; Busson M; Bastuji-Garin S; Roujeau JC; Charron D
    J Autoimmun; 2000 Aug; 15(1):67-73. PubMed ID: 10936030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulvo-cervico-vaginal manifestations and evaluation of Papanicolaou smears in pemphigus vulgaris and pemphigus foliaceus.
    Fairbanks Barbosa ND; de Aguiar LM; Maruta CW; Aoki V; Sotto MN; Labinas GH; Perigo AM; Santi CG
    J Am Acad Dermatol; 2012 Sep; 67(3):409-16. PubMed ID: 22153790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pemphigus Vulgaris and Pemphigus Foliaceus: Differences in Epidemiology and Mortality.
    Kridin K; Zelber-Sagi S; Bergman R
    Acta Derm Venereol; 2017 Oct; 97(9):1095-1099. PubMed ID: 28536732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pemphigus group (vulgaris, vegetans, foliaceus, herpetiformis, brasiliensis).
    Joly P; Litrowski N
    Clin Dermatol; 2011; 29(4):432-6. PubMed ID: 21679871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to the amino-terminal domain of desmoglein 1 are retained during transition from pemphigus vulgaris to pemphigus foliaceus.
    España A; Koga H; Suárez-Fernández R; Ohata C; Ishii N; Irarrazaval I; Teye K; Ohyama B; Hashimoto T
    Eur J Dermatol; 2014; 24(2):174-9. PubMed ID: 24776707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DRB1 and DQB1 genetic susceptibility to pemphigus vulgaris and pemphigus foliaceus in Vietnamese patients.
    Vuong TBT; Do DM; Ong PT; Thanh Le TV
    Dermatol Reports; 2022 Jun; 14(2):9286. PubMed ID: 35795841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.